206 related articles for article (PubMed ID: 10549374)
41. [Influence of a triplex superimposed treatment on HBV replication and mutation during treating chronic hepatitis B].
Wu L; Liu H; Xue P; Lu ZG; Du KF
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2001 Sep; 15(3):236-8. PubMed ID: 11986694
[TBL] [Abstract][Full Text] [Related]
42. [Management and treatment of patients with hepatitis B].
den Eynde EV; Riveiro-Barciela M
Enferm Infecc Microbiol Clin; 2016 Jul; 34 Suppl 3():47-51. PubMed ID: 27474247
[TBL] [Abstract][Full Text] [Related]
43. Hepatitis B virus infection.
Liaw YF; Chu CM
Lancet; 2009 Feb; 373(9663):582-92. PubMed ID: 19217993
[TBL] [Abstract][Full Text] [Related]
44. Host immunity influences disease progression and antiviral efficacy in humans infected with hepatitis B virus.
Wang FS; Zhang Z
Expert Rev Gastroenterol Hepatol; 2009 Oct; 3(5):499-512. PubMed ID: 19817672
[TBL] [Abstract][Full Text] [Related]
45. Sustained hepatitis C virus clearance and increased hepatitis B surface antigen seroclearance in patients with dual chronic hepatitis C and B during posttreatment follow-up.
Yu ML; Lee CM; Chen CL; Chuang WL; Lu SN; Liu CH; Wu SS; Liao LY; Kuo HT; Chao YC; Tung SY; Yang SS; Kao JH; Su WW; Lin CL; Yang HC; Chen PJ; Chen DS; Liu CJ;
Hepatology; 2013 Jun; 57(6):2135-42. PubMed ID: 23322699
[TBL] [Abstract][Full Text] [Related]
46. Management of hepatitis B virus infection during treatment for hepatitis B virus-related hepatocellular carcinoma.
Kubo S; Takemura S; Tanaka S; Shinkawa H; Nishioka T; Nozawa A; Kinoshita M; Hamano G; Ito T; Urata Y
World J Gastroenterol; 2015 Jul; 21(27):8249-55. PubMed ID: 26217076
[TBL] [Abstract][Full Text] [Related]
47. Impact of therapy on the long-term outcome of chronic hepatitis B.
Liaw YF
Clin Liver Dis; 2013 Aug; 17(3):413-23. PubMed ID: 23905813
[TBL] [Abstract][Full Text] [Related]
48. Current therapeutic approaches for HBV infected patients.
Gill US; Kennedy PTF
J Hepatol; 2017 Aug; 67(2):412-414. PubMed ID: 28629790
[No Abstract] [Full Text] [Related]
49. Treatment of chronic hepatitis B.
Cornberg M; Jaroszewicz J; Manns MP; Wedemeyer H
Minerva Gastroenterol Dietol; 2010 Dec; 56(4):451-65. PubMed ID: 21139543
[TBL] [Abstract][Full Text] [Related]
50. A randomized, controlled trial of combination therapy for chronic hepatitis B: comparing pegylated interferon-alpha2b and lamivudine with lamivudine alone.
Chan HL; Leung NW; Hui AY; Wong VW; Liew CT; Chim AM; Chan FK; Hung LC; Lee YT; Tam JS; Lam CW; Sung JJ
Ann Intern Med; 2005 Feb; 142(4):240-50. PubMed ID: 15710957
[TBL] [Abstract][Full Text] [Related]
51. Does treatment with interferon-based therapy improve the natural history of chronic hepatitis B infection?
Lau GK
J Hepatol; 2007 Jan; 46(1):6-8. PubMed ID: 17112628
[No Abstract] [Full Text] [Related]
52. Suppression of interferon-mediated antiviral immunity by hepatitis B virus: an overview of research progress.
Guo P
Scand J Immunol; 2013 Sep; 78(3):230-7. PubMed ID: 23790137
[TBL] [Abstract][Full Text] [Related]
53. Prevention of human hepatocellular carcinoma with natural lymphoblastoid alpha interferon.
Oon CJ
J Gastroenterol Hepatol; 2002 Dec; 17 Suppl():S500-1. PubMed ID: 12534786
[TBL] [Abstract][Full Text] [Related]
54. Oncogenic viruses and hepatocellular carcinoma.
Ben Ari Z; Weitzman E; Safran M
Clin Liver Dis; 2015 May; 19(2):341-60. PubMed ID: 25921667
[TBL] [Abstract][Full Text] [Related]
55. Treatment of chronic hepatitis B with a combination of acyclovir and alpha-lymphoblastoid interferon.
Schalm SW
J Chemother; 1989 Jul; 1(4 Suppl):1112-4. PubMed ID: 16312795
[No Abstract] [Full Text] [Related]
56. From HCV To HBV Cure.
Schinazi RF; Asselah T
Liver Int; 2017 Jan; 37 Suppl 1(Suppl 1):73-80. PubMed ID: 28052627
[TBL] [Abstract][Full Text] [Related]
57. Antiviral therapies for hepatitis B virus-related hepatocellular carcinoma.
Zhang YQ; Guo JS
World J Gastroenterol; 2015 Apr; 21(13):3860-6. PubMed ID: 25852270
[TBL] [Abstract][Full Text] [Related]
58. Update of research and management of hepatitis B.
Okanoue T; Minami M
J Gastroenterol; 2006 Feb; 41(2):107-18. PubMed ID: 16568369
[No Abstract] [Full Text] [Related]
59. Summaries for patients. Antiviral regimens for chronic hepatitis B virus infection.
Ann Intern Med; 2005 May; 142(10):I39. PubMed ID: 15897528
[No Abstract] [Full Text] [Related]
60. Hepatitis B Virus Infection: Overview.
Li H; Yan L; Shi Y; Lv D; Shang J; Bai L; Tang H
Adv Exp Med Biol; 2020; 1179():1-16. PubMed ID: 31741331
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
